2009 Biotechnology Development Information Technology 
Harvard Business Review
MAY 2, 2011
As multinational corporations pursue opportunities in emerging markets, they're bound to stumble if they overlook the developed economies, and vice versa. Without operating in the former, they won't be able to attain economies of scale; sans the latter, they're unlikely to continue developing state-of-the-art technologies.
Harvard Business Review
MARCH 1, 2011
And that's true in many areas: New devices, pharmaceuticals, and surgical techniques regularly get developed and incorporated into practice. Virtually every day, there is information about a clinical study with a new way to treat sick people. And biotechnology and medical devices are among the leading areas for venture capital funding.
Expert insights. Personalized for you.
13 
Let's personalize your content